AVJ16 is a cancer cell migration inhibitor that targets the insulin-like growth factor 2 mRNA binding protein IGF2BP1 with a good affinity of Kd of 1.4µM. AVJ16 interferes with IGF2BP1 binding target mRNA to regulate gene expression and translation[1].
Molecular Weight:
469.53
Purity:
99.60
CAS Number:
[2775241-92-2]
Formula:
C28H27N3O4
Target:
Apoptosis,Insulin Receptor
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
